Login

ADT CEO Jim DeVries Shares Insights on Recent Business Moves and Future Growth Strategies 00:10:00

Share On Facebook Share On Twitter

ADT President and CEO Jim DeVries

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Trading of Caverion Oyj shares (trading symbol: CAV1V) commenced on the NASDAQ OMX Helsinki Main Market on July 1, 2013.
00:10:00
Financial Analysis of ContourGlobal: A Deep Dive into Their Profit Margins and Earnings
00:10:00
Monica Pedroza: Inspired Pro Bono Work at Morgan Lewis | MONICA C. PEDROZA - ASSOCIATE of Morgan, Lewis & Bockius LLP
00:10:00
Black Dragon Gold - Salave Gold Project
00:10:00
Focuses on investing in early-stage digital health companies that will redefine healthcare|Lynne Chou O'Keefe,Founder and Managing Partner,Define Ventures
00:10:00
Karim Henkens on ICT Group's 2022 Milestones | Karim Henkens, CEO, ICT Group.
00:10:00
Advancing the Waterberg Palladium Project: A Game-Changer in Mining
00:10:00
"The Power of Regular Contributions and Early Savings: Sergio Fernández-Pacheco Explores MiFID II's Impact on Investment Strategies"
00:10:00
Blackstone we deliver for investors by building businesses that power tomorrow’s economy|Stephen A. Schwarzman,Chairman,The Blackstone Group
00:10:00
Alan Seabost on Small Business Resilience and M&A Opportunities
00:10:00
Investment in digital bank Revolut, valued at $25.7 billion|Martin Mignot,investor,Index Ventures
00:10:00
O.C.E.A.N Inc. Enhances Employee Retirement Planning with Mutual of America's Support

© 2026 Nehu